Skip to main content
. 2019 Aug 7;18(4):3698–3704. doi: 10.3892/ol.2019.10728

Figure 2.

Figure 2.

CD44 mRNA expression level was evaluated using Oncomine analysis. (A) CD44 mRNA expression in low-grade glioma. (B) CD44 mRNA expression in different grades of gliomas. Normal brain tissues, WHO II (including diffuse astrocytoma and oligodendroglioma), WHO III (anaplastic astrocytoma) and WHO IV (glioblastoma). WHO, World Health Organization.